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TUG and SCT times (sec) at each time point. Values expressed as
mean (95% CI)
Baseline 1 year 2 year
TUG 8.29 (7.95, 8.62) 7.82 (7.53, 8.12) 7.92 (7.56, 8.29)
SCT 13.71 (12.86, 14.56) 12.49 (11.70, 13.28) 12.67 (11.87, 13.46)
Recovery Status on TUG and SCT for patients at 2 year follow-up (Values
expressed as percentages).
Recovered Improved to
Recovered
Improved Unchanged Deteriorated
TUG 33.1 6.6 14.0 38.0 8.3
SCT 29.8 5.0 13.2 47.9 4.1
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CHANGE IN CARTILAGE THICKNESS IN THE FEMOROPATELLATAR
JOINT AFTER ACUTE ANTERIOR CRUCIATE LIGAMENT TEAR – LONG
TERM FOLLOW-UP
S. Cotofana y,z, W. Wirth y,z, F. Eckstein y,z, M. Hudelmaier y,z,
S. Lohmander x, R.B. Frobell x. y PMU-Salzburg, Salzburg, Austria;
zChondrometrics GmbH, Ainring, Germany; xOrthopedics, Clinical Sci.
Lund, Lund University, SwedenTable 1
Change in cartilage thickness between BL-2 years and 2-5 years. Asterisks indicate differences from zero (** p<0.001) within strata for age, BMI and gender (left side); p-values
highlighted in bold indicate signiﬁcances between these strata (right side).
Age<median
(n¼54) Mean /mm
Age<median
(n¼54) SEM
Age>median
(n¼53) Mean /mm
Age>median
(n¼53) SEM
Mean
Difference /mm
Lower 95% CI Upper 95% CI p (2-tailed)
Patella 2.33 10.88 -20.41 13.84 80.29 11.81 148.78 0.022
ACL tear -> 2 years Trochlea -16.38 14.68 -73.94** 15.95 57.56 14.59 100.52 0.009
Patella 14.98 11.34 -22.86 14.36 138.32 43.96 232.68 0.004
2 -> 5 years Trochlea 8.97 9.25 -11.22 11.32 20.19 -8.75 49.13 0.17
BMI<median
(n¼53) Mean /mm
BMI<median
(n¼53) SEM
BMI>median
(n¼54) Mean /mm
BMI>median
(n¼54) SEM
Mean
Difference /mm
Lower 95% CI Upper 95% CI p (2-tailed)
Patella -12.66 13.51 -5.29 11.47 -7.37 -42.45 27.72 0.678
ACL tear -> 2 years Trochlea -22.38 16.18 -66.99** 14.86 44.61 1.08 88.15 0.045
Patella -1.48 13.62 -6.01 12.72 4.54 -32.40 41.47 0.808
2 -> 5 years Trochlea 6.65 10.19 -8.57 10.52 15.22 -13.84 44.27 0.301
Male (n¼81)
Mean /mm
Male (n¼81)
SEM
Female (n¼26)
Mean /mm
Female (n¼26)
SEM
Mean
Difference /mm
Lower
95% CI
Upper
95% CI
p (2-tailed)
Patella -14.46 10.38 8.26 16.29 -22.71 -63.41 17.99 0.271
ACL tear -> 2 years Trochlea -48.50** 13.35 -33.63 19.55 -14.87 -66.53 36.79 0.569
Patella -2.99 10.48 -6.20 20.14 3.21 -39.86 46.28 0.883
2 -> 5 years Trochlea -0.78 8.43 -1.82 15.11 1.04 -33.00 35.08 0.952Purpose: Patellofemoral joint (PFJ) osteoarthritis (OA) is a prevalent
disease affecting young and elderly individuals and is recognized as
a potent source of knee symptoms. Using quantitative MR image anal-
ysis it was reported that the femoral trochlea undergoes cartilage
thinning within the ﬁrst two years after an ACL tear and that such
thinning wasmore frequent in older individuals. It is however unknown
whether these changes continue (and if yes, at which magnitude) over
longer follow-up periods. Thus, the purpose of the present work was to
study the rate of change in cartilage thickness in the PFJ during the
period of 2-5years after ACL tear and to explore differences related to
age, gender and BMI.
Methods: 121 young active adults (32 women, 26.04.9 years) with an
acute ACL tear were included in a randomized control trial (the
KANON-trial). The study compared rehabilitation plus early ACL
reconstruction (n¼62), with rehabilitation plus the option of having
delayed ACL reconstruction if needed (n¼59). Mean cartilage thickness
was assessed by manual segmentation in the patella and femoral
trochlea with blinding to time points and treatment groups. Crude and
adjusted (age, sex & BMI) statistical testing was performed to explore
the magnitude of cartilage loss between baseline (BL, within 4 weeksfrom ACL tear)-2years and 2-5years in the patella and the femoral
trochlea.
Results: 107 of 121 participants had a complete set of MR images at BL,
2 and 5 year follow up. Mean change of cartilage thickness in patella and
trochlea was -8.9mm/[-26.4, 8.5] and -44.9mm/[-67.0, -22.8] (mean/[95%
CI]) over the ﬁrst 2 years after ACL tear and -3.8mm/[-22.1, 14.6] and
-1.0mm/[-15.6, 13.5] over the period between 2-5 years, respectively.
Older patients (above median age, 25.63years) lost signiﬁcantly more
cartilage thickness than younger individuals (below median age) in
both the patella (p¼0.022) and in the trochlea (p¼0.009) over the ﬁrst 2
years. Similar differences were seen in the patella (p¼0.004), but not in
the trochlea (p¼0.17), between 2-5years (Table 1). Compared to indi-
viduals with a lower BMI (belowmedian, 23.66kg/m2), individuals with
a higher BMI (above median) had a signiﬁcant decrease in cartilage
thickness of the trochlea over the ﬁrst 2 years (p¼0.045) but not
between 2-5years. No corresponding differences related to BMI or
gender were observed in the patella (Table 1). In a multi-variate model
including age, BMI and gender, older age at ACL tear signiﬁcantly
increased the odds of losing cartilage thickness in the femoral trochlea
(OR 1.06, 95% CI 1.01, 1.10) over the ﬁrst 2 years after tear and in the
patella (OR 1.04, 1.00, 1.08) in the period 2-5 years.
Conclusions: These results show that cartilage loss in the femoral
trochlea may be an early and temporary event occurring over the ﬁrst 2
years after ACL tear. In contrast to that, cartilage loss in the patellar
cartilage seems to occur later than 2 years after the ACL tear. Older age
seems to be a risk factor for these changes. Our results indicate that
different mechanisms may drive loss of cartilage in the femoropatellar
joint after ACL tear.276
THE VISK STUDY: A PRAGMATIC RANDOMIZED CLINICAL TRIAL FOR
THE EFFECTIVENESS OF INTRA ARTICULAR HYALURONIC ACID FOR
KNEE OSTEOARTHRITIS
J. Hermans y, S.M. Bierma-Zeinstra y, D. Niesten z, J.A. Verhaar y,
M. Reijman y. y Erasmus MC, Rotterdam, The Netherlands; zReinier de
Graaf Hosp., Delft, The Netherlands
Purpose: Usual care for knee osteoarthritis (OA) consists of non-
steroidal anti-inﬂammatory drugs (NSAIDs) combined with physical
therapy. Nevertheless, NSAIDs may cause serious gastrointestinal
symptoms. An alternative treatment for knee OA is intra articular
injections with hyaluronic acid (HA), showing beneﬁcial results on pain,
function and patient global assessment. However, limited evidence of
the additional value of HA to usual care exists. Therefore, the goal of this
investigation was to assess the clinical relevant effect of intra articular
high molecular weight (MW) HA added to usual care compared to usual
care in patients with knee OA.
Methods: Clinical effectiveness and cost utility were investigated
simultaneously in this randomized clinical trial. Consecutive knee OA
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S149patients with mild to moderate knee OA, aged 18-65 years, receiving
usual care for more than 6 months were included. Patients were
randomized into a control group receiving usual care or into an inter-
vention group receiving usual care with 3 additional intra articular
injections with high MW HA. Data on pain during rest / activity, func-
tion and global assessment were collected during 12 months follow-up.
The primary outcome was deﬁned as response to therapy according to
OMERACT-OARSI criteria (improvement of at least 20% in at least 2 of
the 3 following domains: pain in rest / pain during activity, function and
patients global assessment) after 12 months of follow-up. Adverse
events were registered during follow-up.
Results: In total, 156 subjects were included of which 77 patients in the
intervention group and 79 subjects in the control group. There were
statistically signiﬁcant more responders in the intervention groupwhen
pain during rest was included in responder criteria (51.9% versus 26.7%,
p¼0.001) after 12 months. With pain during activity as responder
criteria, this difference was also statistically signiﬁcant favouring the
intervention group (51.9% versus 25.3%, p¼0.001). Also on the indi-
vidual outcomes of the responder criteria signiﬁcant differences were
found between both groups favouring the intervention group.
Conclusions: Intra articular HA added to usual care leads to signiﬁ-
cantly more responders according to OMERACT-OARSI criteria after 12
months.
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THE VISK STUDY: A COST UTILITY ANALYSIS OF INTRA ARTICULAR
HYALURONIC ACID FOR KNEE OSTEOARTHRITIS
J. Hermans y, M. Reijman y, H. Verburg z, S.M. Bierma-Zeinstra y,
M.A. Koopmanschap y. y Erasmus MC, Rotterdam, The Netherlands;
zReinier de Graaf Hosp., Delft, The Netherlands
Purpose: Intra articular hyaluronic acid (HA) is included in treatment
guidelines of the Dutch Orthopaedic Society for the treatment of knee
osteoarthritis (OA). However, it is not reimbursed by insurance
companies in The Netherlands due to the fact that cost-utility of intra
articular HA is unknown for the Dutch healthcare system. The primary
goal of this studywas to determine the cost-utility of intra articular high
molecular weight (MW) HA added to usual care compared to usual care
in patients with knee OA.
Methods: Cost utility and clinical effectiveness were investigated in this
randomized clinical trial. Consecutive knee OA patients with mild to
moderate knee OA, aged 18-65 year, receiving usual care for more than
6 months were included in 2 hospitals in The Netherlands. Patients
were randomized into a control group receiving usual care or into an
intervention group receiving usual care with additionally intra articular
high MW HA. Data on medical costs, productivity costs and quality of
life were collected through questionnaires during 12 months follow-up.
Results: In total, 156 subjects were included of which 77 patients in the
intervention group and 79 subjects in the control group. The mean
annual productivity costs were higher in the intervention group (V6.542
(SD V9.837) versus V5.425 (SD V7.118), p¼0.796). The mean total
medical costs were also higher in the intervention group (V1.656 (SD
V2.331) versus V1.112 (SD V2.084), p¼0.003). The total annual mean
costs were higher in the intervention group (V8.198 (SDV1.1382) versus
V6.537 (SD V7.915), p¼0.383). Patients in the intervention group
experienced ahigher and statistically signiﬁcant quality of life during the
course of the follow-upperiod (p¼<0.0001). The higher costs andhigher
quality of life in the intervention group resulted in a cost-effectiveness
ratio of V79.268 per quality adjusted life year (QALY) using the societal
perspective, and V25.948 per QALY using the healthcare perspective.
Conclusions: Adding Intra articular HA to usual care in knee OA is more
effective, but only moderately cost-effective, regarding current stan-
dards for reimbursement in the Netherlands.
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PARQVE – PROJECT ARTHRITIS RECOVERING QUALITY OF LIFE BY
MEANS OF EDUCATION – A PILOT STUDY IN BRAZIL
M.U. Rezende, G.C. Campos, A.F. Pailo, R. Frucchi, T. Pasqualin,
M.I. Hissadomi, N.L. Brito, F.E. Farias, A.P. Monteiro, C.A. Silva,
C.H. Cernigoy. Faculdade Med. USP, Sao Paulo, Brazil
Purpose: The primary objective was to evaluate the improvement of
pain and function of patients with knee OA exposed to a multidisci-
plinary education program. Secondary Objectives were to evaluate
patients’ weight loss and increase in physical activity.Methods: Two hundred and twenty-two patients (54 men and 168
women) with knee OAwere randomly divided into four groups. Patients
underwent pre-assessment and two days of workshops with a multidis-
ciplinary team composed of psychologists; nutritionist; social workers;
physiotherapists; occupational therapists and orthopedic surgeons.
Patients answered evaluation questionnaires (VAS,WOMAC, LEQUESNE)
at inclusion and one year after classes. Three groups participated in two
workshopswith varying time interval between eachworkshop (Group 1,
3months apart; Group 2, 2 months apart; Group 3, 1 month apart. Group
4, control, only received handouts and video as all patients. Patients
responded how many times a week they exercised during the year.To
compare the means between the groups in the assessments of VAS,
WOMAC, Lequesne and BMI, ANOVA was used with repeated measures.
To compare the average weekly exercises between groups ANOVA was
used. The Tukey test was used for multiple comparisons when signiﬁ-
cance was found. The data were processed in SPSS V. 18.0 and the
signiﬁcance level used for the tests was a ¼ 0.05. Data are presented as
mean (standard deviation) at baseline and after 1 year.
Results: Baseline VAS was 53.33 (27.45) in Group 1, 64.58 (25.96) in
Group 2; 57.81 (24.91); Group 3; and 55.70 (26.71) in Group 4. At one
year the average VAS was according to groups: 1: 55.81(22.90); 2:
52.42(25.93); 3: 52.87(21.78); 4: 57.27(24.72). There was a differ-
ence between groups after one year (p¼0.03) but the Tukey test was not
able to verify which group was different. Baseline WOMAC was
1:43.37(19.15); 2: 46.69(18.65); 3: 45.33(18.33); 4:42.33(18.68)
and at one year: 1:43.29(18.08); 2: 42.33(20.86); 3: 42.65(13.67);
4:43.97(19.43). There was no difference between groups
(p¼0.53).Baseline LEQUESNE: 1:12.16(6.29); 2: 13.46(9.57); 3:
11.81(4.08);4:11.89(4.40) andat oneyear1:11.74(4.05);2:11.41(4.63);3:
11.68(3.62); 4: 11.86(4.30) also showed no difference (p¼0.53). Patientes
from group 4 exercised less average 1.34(2.11) times a week than the
others: 1: 2.96 (2.52) p¼0.00; 2: 2.75(2.58); p¼0.01; 3: 2.76(2.95);
p¼(0.015). BMI was measured at baseline and after a year. There were
signiﬁcant defference between groups: (1 and 4) average¼-7.19; CI95%¼
[-9.94; -4.44]; p¼0.00; (2 and 4) average¼ -4.60; CI95%¼ [-7.35; -1.849];
p¼0.000; (3 and 4) average ¼ -3.55; CI95%¼ [-6.27; -0.83]; p¼0.00.
Conclusions: The educational program (handouts, video, and work-
shops) diminished BMI and increased physical activity of the subjects.
Participating in theworkshops did not improve functional measures but
diminished pain more than just receiving handouts.279
PREOPERATIVE RESISTANCE TRAINING INCREASES MUSCLE
FUNCTION IN PATIENTS DIAGNOSED WITH HIP OSTEOARTHRITIS
SCHEDULED FOR TOTAL HIP ARTHROPLASTY – A RANDOMIZED
EXPLORATIVE TRIAL
A. Hermann y,z, A. Holsgaard-Larsen y, S. Mejdahl z, B. Zerahn x,
S. Overgaard y. yOrthopedic Res. Unit, Dept. of Orthopedics and
Traumatology, Odense Univ. Hosp., Odense, Denmark; zDept. of
Ortopedic Surgery, Herlev Univ. Hosp., Copenhagen, Denmark; xDept. of
Clinical Physiology and Nuclear Med., Herlev Univ. Hosp., Copenhagen,
Denmark
Purpose: Osteoarthritis (OA) of the hip is associated with loss of muscle
function. Resistance training (RT) increases muscle strength and func-
tion in healthy elderly and as postoperative intervention after total hip
arthroplasty (THA) in patients with hip OA. The purpose of the study
was to investigate effects of preoperative progressive (RT) on muscle
power and muscle strength in patients with hip osteoarthritis (OA)
scheduled for THA.
Methods: Eighty patients (50-88 years of age, BMI 27.94.6, 70%
female) diagnosed with hip OA and scheduled for THA were random-
ized into two groups:The intervention group (IG) received supervised
preoperative progressive RT twice a week for a period of 10 weeks. Four
exercises focusing on hip and thigh muscles were performed in 3 series
each with an intensity corresponding to 80% of 1 repetition maximum.
The control group (CG) received ‘care as usual’, deﬁned as surgery
according to the regular waiting list and preoperative information
which included a voluntary home based training program without
any RT.
Leg extension muscle power (Nottingham Powerrig, Nottingham, UK)
and maximum isometric force by isolated hip and knee extension
(custom made dynamometer, National Instruments, Texas, USA), was
measured at baseline (time of inclusion) (T0) and following interven-
tion (1-3 days prior to surgery) (T1).
